Cargando…

Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1(st) and 2(nd) doses of the BNT162b2 vaccine

BACKGROUND: Data regarding the association of antibody levels elicited after immunization with the BNT162b2 mRNA COVID-19 vaccine with epidemiological and clinical parameters are limited. METHODS: We prospectively measured the total (TAbs-RBD) and the neutralizing antibodies (NAbs-RBD) against the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michos, Athanasios, Tatsi, Elizabeth-Barbara, Filippatos, Filippos, Dellis, Charilaos, Koukou, Dimitra, Efthymiou, Vasiliki, Kastrinelli, Evangelia, Mantzou, Aimilia, Syriopoulou, Vasiliki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302834/ https://www.ncbi.nlm.nih.gov/pubmed/34400017 http://dx.doi.org/10.1016/j.vaccine.2021.07.067

Ejemplares similares

2369. kinetics of total and neutralizing SARS-CoV-2 spike antibodies after the 2nd and 3rd dose of the BNT162b2 covid-19 vaccine and association with epidemiological characteristics and breakthrough infection
por: Michos, Athanasios, et al.
Publicado: (2023)

Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis
por: Michos, Athanasios, et al.
Publicado: (2022)

Kinetics of SARS-CoV-2 Spike Antibodies after the Second and Third Dose of the BNT162b2 COVID-19 Vaccine and Association with Epidemiological Characteristics and Breakthrough Infection in a Cohort Study of Healthcare Workers
por: Tatsi, Elizabeth-Barbara, et al.
Publicado: (2023)

Epidemiological study of unusual rotavirus strains and molecular characterization of emerging P[14] strains isolated from children with acute gastroenteritis during a 15-year period
por: Tatsi, Elizabeth-Barbara, et al.
Publicado: (2023)

904. Epidemiology of Rotavirus Group A Mixed Genotypes Isolated from Children with Acute Gastroenteritis over a 15-Year Period
por: Dellis, Charilaos, et al.
Publicado: (2023)

SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
por: Filippatos, Filippos, et al.
Publicado: (2022)

Comparison of a rapid fluorescence immunochromatographic test with an enzyme-linked immunosorbent assay for measurement of SARS-CoV-2 spike protein antibody neutralizing activity
por: Filippatos, Filippos, et al.
Publicado: (2023)

Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
por: Dourdouna, Maria-Myrto, et al.
Publicado: (2023)

Rotavirus epidemiology and genotype distribution in hospitalised children, Greece, 2008 to 2020: A prospective multicentre study
por: Koukou, Dimitra-Maria, et al.
Publicado: (2022)

SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods
por: Tatsi, Elizabeth-Barbara, et al.
Publicado: (2021)

Immune response to SARS‐CoV‐2 in children: A review of the current knowledge
por: Filippatos, Filippos, et al.
Publicado: (2021)

SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence
por: Tatsi, Elizabeth-Barbara, et al.
Publicado: (2021)

694. Unexpected Diversity of Rotavirus Genotypes in Pediatric Population
por: Koukou, Dimitra, et al.
Publicado: (2020)

Post‑COVID‑19 syndrome in children (Review)
por: Filippatos, Filippos, et al.
Publicado: (2022)

Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence
por: Filippatos, Filippos, et al.
Publicado: (2023)

COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus
por: Paschou, Stavroula A., et al.
Publicado: (2022)

Molecular Epidemiology of Enterovirus in Children with Central Nervous System Infections
por: Posnakoglou, Lamprini, et al.
Publicado: (2021)

Serum Spexin is Correlated with Lipoprotein(a) and Androgens in Female Adolescents
por: Bacopoulou, Flora, et al.
Publicado: (2019)

Humoral and Cellular Immunity Are Significantly Affected in Renal Transplant Recipients, following Vaccination with BNT162b2
por: Fylaktou, Asimina, et al.
Publicado: (2023)

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study
por: Paschou, Stavroula A., et al.
Publicado: (2022)

Serum concentrations of BDNF in adolescents with metabolic syndrome: a case-control study between normal - BMI adolescents and adolescents with obesity
por: Bacopoulou, Flora, et al.
Publicado: (2023)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

1399. A Prospective Cohort Study Regarding the Impact of Biofire® FilmArray® Meningitis/Encephalitis (FA) Panel in Children with Suspected Central Nervous System Infection
por: Posnakoglou, Lamprini, et al.
Publicado: (2019)

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
por: Terpos, Evangelos, et al.
Publicado: (2021)

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers
por: Syrimi, Natalia, et al.
Publicado: (2023)

Probiotics in Adolescent Prediabetes: A Pilot RCT on Glycemic Control and Intestinal Bacteriome
por: Stefanaki, Charikleia, et al.
Publicado: (2019)

Clinical characteristics of COVID-19 in neonates and young infants
por: Spoulou, Vana, et al.
Publicado: (2021)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
por: Ko, Geon Young, et al.
Publicado: (2023)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
por: Choi, Seong-Ho, et al.
Publicado: (2023)

Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
por: Karavani, Gilad, et al.
Publicado: (2022)

Rotavirus Gastroenteritis in a Neonatal Unit of a Greek Tertiary Hospital: Clinical Characteristics and Genotypes
por: Koukou, Dimitra, et al.
Publicado: (2015)

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
por: Liu, Yang, et al.
Publicado: (2021)

Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study
por: Papadokostaki, Eleni, et al.
Publicado: (2022)

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ud1pbe5d950glr4lcs9i2hpjbr